研究单位：[1]Peking University First Hospital Beijing, China, 100034[2]Nanjing PLA General Hospital[3]Beijing Children's Hospital[4]Central South University[5]The Children's Hospital of Zhejiang University School of Medicine[6]First Affiliated Hospital, Sun Yat-Sen University[7]Tongji Hospital[8]Hunan Children's Hospital[9]Shanghai Children's Hospital[10]Nanjing Children's Hospital[11]Children's Hospital of Chongqing Medical University[12]Shandong Provincial Hospital[13]Fuzhou General Hospital[14]Second Affiliated Hospital of Wenzhou Medical University[15]Children's Hospital of Hebei Province[16]Guangzhou Women and Children's Medical Center[17]Jiangxi Province Children's Hospital[18]Guangzhou First People's Hospital[19]Xian Children's Hospital[20]Capital Institute of Pediatrics, China[21]The First Hospital of Jilin University[22]Wuhan Women and Children's Medical Center[23]Tianjin Children's Hospital[24]Chengdu Women's and Children's Central Hospital[25]The First People's Hospital of Yunnan
研究目的：
This study tries to identify the safe and effective treatment option for IgA nephropathy in children. Investigators will perform prospective registration study among 25 pediatric nephrology medical centers in China.
